NeuraSim Health in collaboration with QWR - Fabless OEM XR Hardware manufacturer are transforming the future of eye care with BeeVee™—India’s first AI-powered VR wearable for amblyopia treatment. Recently featured on Shark Tank India, this revolutionary digital therapeutic is clinically proven to deliver mild to severe recovery in just 1-3 months, offering a groundbreaking, non-invasive alternative to traditional vision therapy. After extensive market testing, BeeVee™ is now officially launching home therapy in the Indian market to make it accessible.
Amblyopia, or lazy eye, is a rare eye condition which is estimated to jump 175.2 million by 2030 worldwide, making it the most common cause of childhood vision impairment. Traditional treatments like eye patching are slow, uncomfortable, and often ineffective due to poor compliance. BeeVee™ transforms this approach with AI-driven VR therapy, using adaptive exercises to retrain the brain and improve vision faster, more effectively, and with greater engagement. Recognizing the need for greater accessibility and comfort for patients, the brand will also offer at-home therapy sessions across India.
Unlike conventional treatments, BeeVee™ offers:
Immersive Gamified Therapy – Instead of patching the stronger eye, BeeVee™ uses fun, interactive VR games that train both eyes together, improving binocular vision.
AI-Driven Adaptive Training – Adjusts difficulty levels in real-time based on the user’s response, ensuring optimal therapy progress.
Neuroplasticity Activation – The therapy stimulates brain pathways responsible for vision, helping retrain the lazy eye more effectively than passive treatments.
Home-Based & Clinically Monitored – Patients can use BeeVee™ at home, while doctors monitor progress remotely, reducing clinic visits and increasing accessibility.
Shorter, More Effective Sessions – BeeVee™ sessions are short and engaging, improving compliance while accelerating visual improvement.
“Being featured on Shark Tank India was a defining moment in our mission to revolutionize eye care in India. Bringing the country’s first AI-powered VR wearable to market is just the beginning, we are now focused on making BeeVee™ accessible in every home, ensuring that no child has to struggle with amblyopia due to outdated treatments.” said Dr. Ramesh S Ve, Founder & CEO, NeuraSim Health.
Suraj Aiar, Founder, QWR, stated, “We are proud to be a part of this breakthrough in eye care. At QWR, our mission is to harness technology to create meaningful change, and BeeVee™ is a step towards that vision. By integrating XR and AI, we are making advanced vision therapy more accessible while contributing to India’s growing presence on the global health-tech stage. We look forward to more such collaborations and the opportunity to transform lives.
Looking ahead, NeuraSim and QWR are pushing the boundaries of medical XR, developing breakthrough solutions that extend far beyond amblyopia treatment. Their pipeline includes Neurametry, an AI-driven eye-tracking system for early detection of glaucoma and neuro-diseases; NeuraSport XR, a cutting-edge performance-enhancing tool for elite athletes that combines eye-tracking with cognitive training; and NeuroXR, an advanced EEG and XR-based platform for neurodegenerative screening and therapy, enabling early diagnosis and better patient outcomes.
𝐒𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐮𝐩𝐝𝐚𝐭𝐞𝐬 𝐛𝐲 𝐣𝐨𝐢𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 WhatsApp Channel now! 👈📲
𝑭𝒐𝒍𝒍𝒐𝒘 𝑶𝒖𝒓 𝑺𝒐𝒄𝒊𝒂𝒍 𝑴𝒆𝒅𝒊𝒂 𝑷𝒂𝒈𝒆𝐬 👉 Facebook, LinkedIn, Twitter, Instagram
